Výsledky vyhledávání - "Roxanna Seyedin"

Chimeric Antigen Receptor T-Cell Therapy Setting of Care: A Retrospective Cohort Analysis of MCL and FL Patients in the US

Autor: Roxanna Seyedin, Ken Hasegawa, Krithika Rajagopalan, Sally W Wade

Publikováno v: Blood. 140:3642-3643

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::72f894faab62f5a38c117bdf99da4cd4
https://doi.org/10.1182/blood-2022-157473

Zobrazit plný text záznamu

Chimeric Antigen Receptor (CAR) T-Cell Therapy Setting of Care: A Retrospective Cohort Analysis of MCL and FL Patients in the United States (US)

Autor: Roxanna Seyedin, Ken Hasegawa, Krithika Rajagopalan, Sally Wade

Publikováno v: Transplantation and Cellular Therapy. 29:S381

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fab14a812cea5544be45f000c49ecf5a
https://doi.org/10.1016/s2666-6367(23)00577-8

Zobrazit plný text záznamu

Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson’s Disease Psychosis: Systematic Review and Network Meta-Analysis

Autor: Ismaeel Yunusa, Nazia Rashid, Roxanna Seyedin, Deepika Paratane, Krithika Rajagopalan

Publikováno v: Journal of Geriatric Psychiatry and Neurology. :089198872311549

Background The current comparative efficacy, safety, and acceptability of atypical antipsychotics (AAPs) in treating Parkinson's Disease Psychosis (PDP) are not entirely understood. Objective To evaluate comparative efficacy, safety, and acceptabilit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9822082fce04eb9270c995156c7a1cbe
https://doi.org/10.1177/08919887231154933

Zobrazit plný text záznamu

Chimeric Antigen Receptor T-Cell Therapy Treatment Patterns: A Retrospective Cohort Analysis of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients in the US

Autor: Krithika Rajagopalan, Roxanna Seyedin, Usama Gergis, Julia Thornton Snider, Sally W. Wade

Publikováno v: Blood. 138:1424-1424

Introduction Patients with relapsed or refractory Diffuse large-B-cell lymphoma (RR DLBCL) have historically had limited treatment options. The approval of chimeric antigen receptor T-cell (CAR T) therapy in 2017 offered a significant survival benefi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eea8b04c2e243027f914426619e1d6cd
https://doi.org/10.1182/blood-2021-148067

Zobrazit plný text záznamu

Using Self-reports or Claims to Assess Disease Prevalence

Autor: Henu Zhao, Bryan Tysinger, Dana P. Goldman, Roxanna Seyedin, Étienne Gaudette, Patricia St. Clair

Publikováno v: Medical Care. 55:782-788

Background Two common ways of measuring disease prevalence include: (1) using self-reported disease diagnosis from survey responses; and (2) using disease-specific diagnosis codes found in administrative data. Because they do not suffer from self-rep

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abdd6c44969011cb91e318097ee719b4
https://doi.org/10.1097/mlr.0000000000000753

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání